Subject to satisfactory completion - i hope you understand the meaning of this.
let me elaborate for you since all you know is 100M 16M MC 6M cash blah blah blah
Clinical trials, especially Phase 1, carry inherent risks. If Phase 1 trials do not meet expectations (e.g., due to safety concerns, insufficient efficacy, or other issues), Nyrada's ability to move forward with Phase 2 trials will be jeopardized
It could very well work out but it is 100% BINARY PUNT
PS: whosoever is blocking or reporting Bendu repeats to HC -WELL DONE
NYR Price at posting:
7.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)